Coronal T2-weighted (T2W) MRI scans (2D TurboRAGE) of the whole brain were performed with a vertical-bore 9.4 T Bruker AVANCE 400WB imaging spectrometer with a 250 mTm 1 actively shielded imaging gradient insert (Bruker BioSpin, Billerica, MA) controlled by Paravision software
Recombinant platelet-derived growth factor (PDGF), which is growth factor-based therapy, has also been given to promote cell proliferation and the formation of granulation tissue
In early clinical trials, patients on GLP-1 agonists have achieved weight loss of 1520%, compared to the 510% typically seen with previous medications. Holistic approach to GLP-1 drugs Beyond weight loss, GLP-1 agonists have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux
Pregnant or nursing individuals are typically advised to avoid GLP-1 treatments
Nutrients , 11 (10), 2412.